Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Richard Derner

Podiatrist, Foot & Ankle Surgery Lake Ridge, VA Doctor of Podiatric Medicine

NPI 1932177607 CMS profile 86877

1721 Financial Loop, Lake Ridge, VA 22192

Open in the dashboard

General payments

$211,540

214 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$75,185

2 holdings reported · through program year 2025

Research they led as principal investigator

$21,348 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Richard Derner of Lake Ridge, VA is reported in the CMS Open Payments database as having received $211,540 across 214 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $21,348 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $75,185 across 2 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $17,292 32
2024 General $7,591 35
2023 General $29,429 41
2022 General $43,339 38
2021 General $72,456 31
2020 General $21,270 12
2019 General $20,162 25
2020 Ownership $41,741 1
2019 Ownership $33,445 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Richard Derner
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Richard Derner were reported at $17,292. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Richard Derner Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $20,162 $389 $118–$1,406 $163
2020 $21,270 $191 $62–$691 $114
2021 $72,456 $329 $104–$1,341 $132
2022 $43,339 $419 $125–$1,611 $149
2023 $29,429 $377 $128–$1,164 $160
2024 $7,591 $394 $134–$1,168 $164
2025 $17,292 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Flower Orthopedics Coporation $77,815 57 payments
  2. MedShape, Inc. $57,521 1 payment
  3. New Standard Device, LLC dba Metalogix $43,796 3 payments
  4. Anika Therapeutics, Inc. $10,106 10 payments
  5. Fusion Orthopedics USA, LLC $9,806 8 payments
  6. Zimmer Biomet Holdings, Inc. $4,345 19 payments
  7. Stryker Corporation $4,173 44 payments
  8. OSSIO Inc. $1,594 10 payments
  9. Ortho Solutions Inc $309 2 payments
  10. Wright Medical Technology, Inc. $268 4 payments
  11. Other $1,806 56 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $73,042 25 payments
  2. Acquisitions $57,521 1 payment
  3. Consulting Fee $57,308 18 payments
  4. Travel and Lodging $9,879 17 payments
  5. Food and Beverage $9,508 137 payments
  6. Education $4,281 16 payments
Products named General payments · program years 2019–2025
  1. MTP Plate, 5 Holes, Left $9,163 8 payments
  2. Lapidus Plate, Beta $9,163 8 payments
  3. MTP Plate, 5 Holes, Right $9,163 8 payments
  4. Lapidus Plate, Alpha $9,163 8 payments
  5. Medial Column Plate, Right $8,075 7 payments
  6. Fibula Nail, 4.5mm x 180mm, Titanium, Flex-Thread $7,989 11 payments
  7. Fibula Nail, 4.5mm x 130mm, Titanium, Flex-Thread $7,989 11 payments
  8. Fibula Nail, 3.5mm x 180mm, Titanium, Flex-Thread $7,989 11 payments
  9. ZERO Profile Interlocking Cortex Screw, 2.7mm x 14mm, T8, Flex-Thread $7,989 11 payments
  10. Fibula Nail, 3.5mm x 130mm, Titanium, Flex-Thread $7,989 11 payments
  11. Other $24,596 154 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

150

Median for Podiatry: 160

Drug cost

$19,503

Median for Podiatry: $2,368

Branded share of claims

47.3%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 31 $17,846
Cephalexin Generic 32 $624
Gabapentin Generic 26 $419
Ondansetron Odt Ondansetron Brand 18 $338
Oxycodone Hcl Generic 21 $144
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 22 $133

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 94 billing codes

Paid by Medicare

$159,292

Of which drugs: $69

Medicare patients

386

Average age 73

Services billed

2,267

230 women, 156 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Diabetes 38%
Ischemic heart disease 27%
Atrial fibrillation 19%
Chronic kidney disease 17%
Depression 17%
Osteoporosis 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 56 93 $67

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Exparel
  • Pacira Pharmaceuticals Incorporated $11
$11 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

214 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record